To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Woburn biotech is rehiring ...

Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that ...

Amjad Masad and Haya Odeh built Replit together from scratch. Can they defend its position as an industry juggernaut?

A shareholder class action lawsuit has been filed against Replimune Group, Inc. (“Replimune”) (NASDAQ: REPL). The lawsuit ...

After two rejections and layoffs that eliminated more than 200 jobs, Massachusetts biotech Replimune Group finally secured ...

Replit, Kilo Code, and Symbotic engineering leaders reveal how they track AI coding costs and stop runaway token spend before ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Since the large language model (LLM) explosion started, companies have been trying to solve the problem of overflowing inboxes by using AI to categorize emails and draft replies that sound like you.

Replimune Group, Inc.'s RP1 has failed at the FDA twice, but Makary's resignation keeps a resubmission possible. REPL's cash runway stands at under a year; workforce cuts and RP1 discontinuation are ...

This project is a proof-of-concept that runs a JavaScript engine inside a web browser by compiling it to WebAssembly. The engine is Goja — a pure-Go implementation of ECMAScript 5.1 — and the ...

In July 2025, REPL announced it had received a CRL for its biologics license application (BLA) for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma patients who were PD-1 ...